Now, the Chicago-based pharma is heading southwest as it charts the next leg of its stateside investment tour.

Wilmington PharmaTech ("WPT"), a U.S.-based specialty contract research, development and manufacturing organization (CRDMO) focused on complex custom small molecule API, today announced that it has ...

ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market. To ...

In the regulated pharmaceutical sector, maintaining awareness and connectivity is vital. Industry professionals attend ...

Mandara Biopharma Inc., a privately held U.S.-based biopharmaceutical company focused on novel therapies for central nervous system (CNS) disorders, today announced that it has filed an ...

Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova Limited, and a global CRDMO operating from five sites across India and Europe, – announced the opening of a new discovery and ...

Investec says Rubicon’s R&D, capital allocation and acquisition strategy has created a ROI-led growth engine across its ...

As Indian pharma pivots toward innovation and sustainability, Granules India charts strong growth, R&D and global ambitions ...

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today provided a business update including preliminary total revenue and net product ...

The Union Budget 2026 Session is set to start in Parliament from 28 January. Finance Minister Nirmala Sitharaman is likely to ...

Minaris and Genetix Biotherapeutics have expanded their manufacturing partnership to increase commercial-scale production of ...

AbbVie's $175M investment in a Tempe manufacturing facility is part of a larger expansion strategy. Here's what the Chicago ...